Cardinal Health
0
Funds holding %
of 7,419 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
112% more first-time investments, than exits
New positions opened: 174 | Existing positions closed: 82
24% more call options, than puts
Call options by funds: $281M | Put options by funds: $227M
22% more funds holding in top 10
Funds holding in top 10: 9 [Q3] → 11 (+2) [Q4]
8% more capital invested
Capital invested by funds: $23B [Q3] → $24.8B (+$1.78B) [Q4]
8% more funds holding
Funds holding: 1,000 [Q3] → 1,076 (+76) [Q4]
0% more repeat investments, than reductions
Existing positions increased: 372 | Existing positions reduced: 371
0.13% less ownership
Funds ownership: 86.09% [Q3] → 85.95% (-0.13%) [Q4]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$136
1%
downside
Avg. target
$146
6%
upside
High target
$155
13%
upside
6 analyst ratings
4 positive
67%
2 neutral
33%
0 negative
0%
B of A Securities Michael Cherny 69% 1-year accuracy 20 / 29 met price target | 13%upside $155 | Buy Maintained | 11 Apr 2025 |
Mizuho Steven Valiquette 29% 1-year accuracy 2 / 7 met price target | 9%upside $150 | Outperform Maintained | 31 Mar 2025 |
Jefferies Brian Tanquilut 22% 1-year accuracy 2 / 9 met price target | 9%upside $150 | Buy Upgraded | 5 Feb 2025 |
JP Morgan Lisa Gill 63% 1-year accuracy 15 / 24 met price target | 5%upside $145 | Neutral Maintained | 4 Feb 2025 |
Wells Fargo Stephen Baxter 32% 1-year accuracy 10 / 31 met price target | 1%downside $136 | Equal-Weight Maintained | 4 Feb 2025 |
Financial journalist opinion
Based on 16 articles about CAH published over the past 30 days
Positive
Zacks Investment Research
1 day ago
Cardinal Health (CAH) Reports Next Week: Wall Street Expects Earnings Growth
Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Negative
Zacks Investment Research
3 days ago
Cardinal Health (CAH) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Cardinal Health (CAH) closed the most recent trading day at $133.69, moving +1.92% from the previous trading session.

Positive
Zacks Investment Research
3 days ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Positive
Zacks Investment Research
4 days ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Neutral
Zacks Investment Research
1 week ago
Cardinal Health (CAH) Ascends While Market Falls: Some Facts to Note
Cardinal Health (CAH) closed the most recent trading day at $134.36, moving +0.08% from the previous trading session.

Positive
Zacks Investment Research
1 week ago
4 Stocks to Watch as Dental Supplies Recovers Amid Tariff Headwind
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, MMSI, XRAY and CNMD.

Positive
Zacks Investment Research
2 weeks ago
Here's Why Cardinal Health (CAH) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Positive
Barrons
2 weeks ago
ESG Still Matters. 3 Defensive Stocks That Make the Grade.
Cardinal Health, Atmos Energy, and General Mills make the cut for one ESG fund manager.

Positive
Zacks Investment Research
3 weeks ago
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Positive
Zacks Investment Research
3 weeks ago
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?
Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Charts implemented using Lightweight Charts™